The Valley Desk

Clinical trial reportThe New England journal of medicinePublished

Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
The New England journal of medicine
Published
Subject terms
Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Thromboembolism; Hypertension; Fatigue; Diarrhea; Anilides; Pyridines; Antineoplastic Agents; Treatment Outcome; Double-Blind Method
PubMed ID
39282913
PubMed Central ID
PMC11821447
Added to directory
Source checked

Report a correction or request removal